Mechanistically, it has been demonstrated that upregulation of DDIT3 blunts tbx21 transcription in tumor-infiltrating CD8+ T cells, impairing T-cell effector immunity and indicating regulation of their antitumor activity [36]. The gene discussed is DDIT3; the disease is neoplasm.